The KAYS Weeder

Since the legal cannabis industry burst onto investors’ radar in 2014 the U.S. market and the Canadian markets have been the primary focus. The potential of the U.S. market in terms of sheer size, and the Canadian national recreational program and export opportunities have captured investor attention.    Interestingly, there are some U.S. and Canadian companies that are focused on opportunities they see in the emerging markets outside of North America. For example, the European Union medical cannabis market could be worth $64 billion by 2028. Yet, in many cases these companies are undervalued as the overseas operations are largely ignored by investors.    Let’s take a look at three international cannabis opportunities that investors may want to consider as they diversify their portfolio.   #1. Aphria is a Dominant Force in Germany   Aphria Inc.  (TSX: APHA) (NASDAQ: APHA) recently merged with  Tilray Inc.  (NASDAQ: TLRY) to consolidate operat...

  Many investors seek out two types of opportunities: Value stocks that generate consistent cash flow at a reasonable valuation and Growth stocks that are more risky, but have the prospect of higher returns.    Perhaps an example of a hybrid of the two is  Kaya Holdings Inc.  (OTCQB: KAYS), which has Oregon-based cannabis operations that could provide stable income while the Company develops a number of ambitious overseas projects in Greece and Israel. While management’s international ambitions represent a growth opportunity that could unlock significant shareholder value, there are legitimate concerns of high costs of entry, shareholder dilution and diversion of management attention .   Kaya Holdings may present a mix between value and growth, and with its experienced management team and their responses to investor concerns, investors in both growth and value stocks should pay close attention.   Proven Oregon Model   Kaya Holdings opened its firs...